Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The prevalence of abnormal liver tests in people hospitalized with COVID-19 is higher than previously found.
So found a study of more than 1,500 people treated for hep C, including almost 600 people with compensated advanced chronic liver disease.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.